FundedIQ
Biotechnology

Immuto Scientific: Funding, Investors & Team (Sep 2026)

Immuto Scientific is a biotechnology company that offers analytic insights to pharmaceutical companies to help with the process of discovering new drugs.

www.immutoscientific.com LinkedIn Madison, United States 11-50 employees
Biotechnology Pharmaceutical B2B
Total raised
$10.6M
Rounds
3
Latest
Seed
Sep 2025

Immuto Scientific has raised $10.6M across 3 funding rounds on record, the most recent a Seed of $8.0M announced in Sep 2025.

That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Immuto Scientific Company Profile and Key Stats

Total funding raised
$10.6M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Seed
$8.0M in Sep 2025
Employees
11-50
reported band
Headquarters
Madison, United States

Latest funding round on record: Sep 2025.

Immuto Scientific Funding Rounds

Date
Round
Amount
Seed
$8.0M
Undisclosed round
$100k
Grant
$2.5M

Immuto Scientific raised $2.5M in a Grant announced in Aug 2022.

2.5 years later, an undisclosed round of $100k was announced in Feb 2025.

7 months later, a Seed of $8.0M was announced in Sep 2025.

Immuto Scientific Founders and Leadership Team

Name
Role
Contact
Daniel Benjamin
Founder
Mike Sussman
Founder
Faraz A. Choudhury, PhD
Locked

Contact details for the Immuto Scientific team: 1 of 3 have an email address on file.

Start 14-day free trial →

Immuto Scientific Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
16,485
$3.1M

Immuto Scientific's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Immuto Scientific in Biotechnology and Madison

Companies Similar to Immuto Scientific

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Immuto Scientific Funding FAQs

What does Immuto Scientific do?

Immuto Scientific is a biotechnology company that offers analytic insights to pharmaceutical companies to help with the process of discovering new drugs.

How much funding has Immuto Scientific raised?

Immuto Scientific has raised $10.6M across 3 rounds on record. The most recent is a Seed of $8.0M announced in Sep 2025.

When did Immuto Scientific last raise funding?

Immuto Scientific's most recent funding round on record is a Seed of $8.0M, announced in Sep 2025.

Who founded Immuto Scientific?

FundedIQ lists Daniel Benjamin (Founder), Mike Sussman (Founder) at Immuto Scientific.

Where is Immuto Scientific headquartered?

Immuto Scientific is based in Madison, Wisconsin, United States.

How many employees does Immuto Scientific have?

Immuto Scientific is in the 11-50 employee band.

How does Immuto Scientific's funding compare to other Biotechnology startups?

Immuto Scientific's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Immuto Scientific Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immuto Scientific is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.